Non-invasive prenatal testing of pregnancies at risk for phenylketonuria

Abstract

The NIPT cSMART PKU assay was highly sensitive and specific for mutation detection and correct assignment of fetal genotypes. Based on comprehensive mutation coverage across the <i>PAH</i> gene, the assay may initially have clinical utility as a pregnancy screening test for high-risk carrier couples.